IDH2 and astrocytoma (excluding glioblastoma): This attribute gains importance given that, amongst WHO Grade 2/3 astrocytomas, oligodendrogliomas, and glioblastomas developing from these lower grade entities, IDH1 mutation occurs at codon number 132 in over two-thirds of these, with IDH2 mutations occurring in 6% of them [13].